1. Disease Overview

Mitral valve disease is any condition that stops the mitral valve — the two-leaflet “door” between the left atrium and the left ventricle — from opening and closing properly. In a healthy heart it opens to let oxygen-rich blood flow from the upper left chamber into the main pumping chamber, then snaps shut to stop blood leaking backward as the ventricle contracts.

When the valve leaks, blood flows the wrong way back into the atrium — mitral regurgitation (MR). When it becomes stiff and narrowed, blood cannot pass through easily — mitral stenosis (MS). Some people have both at once (mixed disease), and a related condition, mitral valve prolapse, is a common cause of a leaking valve.

Left unaddressed, significant mitral valve disease forces the left atrium and ventricle to work harder, gradually enlarging and weakening the heart and raising pressure in the lungs. This can lead to breathlessness, tiredness, irregular heartbeats and, eventually, heart failure. The good news is that the condition is highly treatable. Many people are monitored for years without intervention, and when treatment is needed, modern mitral valve repair, replacement and catheter-based options such as the MitraClip offer excellent long-term results. This guide explains the condition in plain language for patients and families, including options for care abroad.

2. Key Facts at a Glance


Also known as	Mitral regurgitation, mitral stenosis, mitral insufficiency, leaky/narrowed mitral valve
Body system affected	Cardiovascular system (left side of the heart and lungs)
Common in	Older adults (degenerative MR); people with past rheumatic fever (MS)
Severity range	Mild and symptom-free to severe, life-limiting heart failure
Key treatments	Monitoring, medications, mitral valve repair, replacement, MitraClip, balloon valvuloplasty
Outlook	Very good when treated at the right time, especially with valve repair

3. Alternative Names and Medical Terminology

Mitral regurgitation (MR) — also called mitral insufficiency or a “leaky” mitral valve
Mitral stenosis (MS) — a “narrowed” or “tight” mitral valve
Mitral valve prolapse (MVP) — bulging leaflets; historically “floppy valve” or Barlow’s syndrome
Degenerative / myxomatous mitral valve disease — age- and tissue-related leaflet weakening
Functional or secondary MR — leak caused by heart-muscle disease rather than the valve itself
Abbreviations you may see: MVR (mitral valve replacement), MVr (mitral valve repair), TEER (transcatheter edge-to-edge repair)

4. Relevant Heart, Lung or Vascular Anatomy

The mitral valve sits between the left atrium (which receives oxygen-rich blood from the lungs) and the left ventricle (the heart’s main pumping chamber). It has two leaflets — the larger anterior and the smaller posterior leaflet — that meet to form a seal.

The valve is a complex apparatus, not just a flap. The leaflets attach to a ring called the annulus, and their free edges are anchored by thin cords, the chordae tendineae, which connect to muscle bumps in the ventricle wall called papillary muscles. Damage to any part of this system can cause the valve to leak or narrow. Because the valve sits between the lungs and the body’s main pump, disease here directly affects the pulmonary circulation — which is why breathlessness is such a common symptom.

5. How the Disease Affects the Body

The two main forms of mitral valve disease strain the heart in different ways.

In mitral regurgitation, each heartbeat pushes some blood backward into the left atrium instead of forward to the body. The heart compensates by pumping harder and the left ventricle enlarges to handle the extra volume, but over time this “volume overload” tires and weakens the muscle. Blood also backs up into the atrium, raising pressure there and in the lungs and stretching the atrium — which encourages atrial fibrillation.

In mitral stenosis, the narrowed valve acts like a partly blocked doorway. Blood struggles to empty from the left atrium, so pressure builds behind the valve and rises into the lungs, causing pulmonary congestion (breathlessness, especially lying flat) and, over years, straining the right side of the heart. The enlarged, high-pressure atrium is again prone to atrial fibrillation and clot-related stroke.

In both cases, the left-heart chambers and the lungs bear extra load. Symptoms develop slowly and the body adapts for years, which is why the disease can quietly progress before a person notices they are unwell.

6. Types and Classification

Mitral regurgitation (leaking) — the most common form. Divided into:
- Primary (degenerative/organic) MR — the valve itself is damaged (e.g. prolapse, ruptured cord, rheumatic scarring)
- Secondary (functional) MR — the valve is structurally normal but leaks because the ventricle or atrium is enlarged or weakened
Mitral stenosis (narrowing) — most often caused by past rheumatic fever; occasionally by heavy calcium deposits (degenerative MS)
Mixed mitral valve disease — both leaking and narrowing together
Mitral valve prolapse — leaflets bulge back into the atrium; may or may not cause a leak
Severity is graded as mild, moderate or severe for both regurgitation and stenosis.

7. Causes of the Disease

Common causes of mitral valve disease include:

Age-related degeneration (myxomatous disease) — leaflets and cords weaken and stretch; the leading cause of MR in high-income countries
Rheumatic fever — immune reaction after untreated strep throat; the main cause of mitral stenosis worldwide
Mitral valve prolapse — often mild, sometimes progressing to significant leak
Ruptured chordae tendineae — a snapped cord causes sudden severe leaking
Coronary artery disease, heart attack and cardiomyopathy — damage or ventricle enlargement causes functional MR
Infective endocarditis — infection destroys valve tissue
Congenital abnormalities and, rarely, connective-tissue disorders or radiation

8. How the Disease Develops

Mitral valve disease usually develops gradually. In degenerative regurgitation, the leaflet tissue slowly loses strength over years; the cords stretch, the leaflets billow, and the seal becomes less tight. A small leak may stay mild for a long time, or worsen suddenly if a supporting cord ruptures, tipping the valve into severe regurgitation.

In rheumatic mitral stenosis, the initial infection may have occurred in childhood decades earlier. The immune reaction leaves the leaflets scarred and fused; calcium gradually accumulates, and over 10–30 years the opening narrows enough to obstruct blood flow, which is why symptoms often first appear in adulthood.

In functional MR, the sequence is reversed: a heart attack or cardiomyopathy enlarges the ventricle first, pulling the leaflets apart, so a structurally normal valve begins to leak. As the leak worsens it enlarges the heart further, creating a vicious cycle. Throughout, the heart compensates, which explains why many patients feel well until the disease is advanced.

9. Risk Factors

Non-modifiable factors:

Increasing age
Previous rheumatic fever or untreated streptococcal infections
Family history of valve disease or connective-tissue disorders
Prior heart attack or heart-muscle disease

Modifiable or preventable factors:

Untreated strep throat (preventable with antibiotics)
Uncontrolled high blood pressure
Coronary artery disease and its risk factors (smoking, diabetes, high cholesterol)
Intravenous drug use (raises endocarditis risk)
Poor dental and general health, which can allow valve infections

10. Genetic and Family-History Factors

Most mitral valve disease is acquired rather than inherited, but genetics play a role in some forms. Mitral valve prolapse can run in families and is more common in people with inherited connective-tissue conditions such as Marfan syndrome, Ehlers-Danlos syndrome and Loeys-Dietz syndrome. If a close relative has prolapse or needed valve surgery young, mention this to your doctor — an echocardiogram can screen family members. Genetic testing is not routine but may be offered when a hereditary syndrome is suspected.

11. Who Is Most at Risk?

Older adults — degenerative regurgitation becomes far more common with age
People from regions where rheumatic fever remains common — South Asia, sub-Saharan Africa, the Pacific and parts of the Middle East and Latin America
Migrants who had rheumatic fever in childhood
Younger women — more likely to develop rheumatic mitral stenosis
People with tall, slim, connective-tissue-disorder body types (prolapse)
Heart-attack and heart-failure patients (functional MR)
People with prior valve infection or an artificial valve

12. Prevalence and Epidemiology

Mitral valve disease is one of the most common valve conditions worldwide. Some degree of mitral regurgitation is found in a large share of older adults, though most cases are mild. Mitral valve prolapse affects an estimated 1–3% of people, and moderate-to-severe regurgitation becomes increasingly common with age, making it a leading reason for valve surgery in high-income countries.

Rheumatic mitral stenosis is now rare in North America and Western Europe but remains a major problem in low- and middle-income countries, where rheumatic heart disease affects tens of millions, disproportionately young women. These figures are broad estimates that vary by region, age and diagnostic method.

13. Signs and Symptoms

Many people with mild or moderate disease have no symptoms and are only diagnosed when a doctor hears a murmur. When symptoms appear they often come on gradually and may be blamed on ageing or being out of shape. Common symptoms include:

Shortness of breath, especially on exertion or when lying flat (orthopnoea)
Fatigue and reduced exercise tolerance
Palpitations — a fluttering or racing heartbeat, often from atrial fibrillation
Cough, sometimes worse at night
Lightheadedness or dizziness
Swelling of the ankles, feet or abdomen (in advanced disease)
Waking at night breathless (paroxysmal nocturnal dyspnoea)

Because the heart compensates for a long time, a sudden worsening of symptoms — for example after a cord ruptures or atrial fibrillation begins — can be the first clear sign that the valve problem is significant.

14. Early-Stage Symptoms

Early mitral valve disease is frequently silent. When subtle symptoms appear first, they usually include:

Mild breathlessness only during vigorous activity
Getting tired more easily than usual
Occasional palpitations or a sense of skipped beats
A heart murmur found incidentally at a routine check-up

At this stage, many patients feel well and are simply monitored with periodic echocardiograms rather than treated.

15. Advanced-Stage Symptoms

As the disease progresses and the heart can no longer compensate, symptoms become more limiting:

Breathlessness with mild activity or at rest
Waking at night short of breath; needing extra pillows to sleep
Persistent fatigue and weakness
Frequent or sustained atrial fibrillation
Swelling of the legs and abdomen (fluid retention)
Coughing up frothy or blood-tinged sputum (in severe stenosis)
Fainting or near-fainting

These features signal significant heart strain or heart failure and usually mean it is time to consider intervention.

16. Symptoms in Women, Men and Older Adults

Women are more likely to develop rheumatic mitral stenosis, and symptoms may first surface during pregnancy, when blood volume rises; their fatigue and breathlessness are sometimes wrongly attributed to anxiety or deconditioning. Men more commonly develop degenerative regurgitation and coronary-related functional MR. Older adults often have several conditions at once, so valve symptoms overlap with lung disease, anaemia or frailty and are easy to miss; atrial fibrillation may be the first clue. Regardless of sex or age, unexplained breathlessness or fatigue warrants a heart check.

17. Emergency Warning Signs

Seek emergency care immediately if you or someone else experiences:

Sudden, severe shortness of breath, unable to lie flat
Chest pain or pressure
Fainting or collapse
Coughing up pink, frothy or bloody sputum
Signs of stroke — face drooping, arm weakness, slurred speech (call emergency services at once)

These may indicate acute severe regurgitation, pulmonary oedema, or a clot-related stroke from atrial fibrillation.

18. When to Seek Medical Help

Book a non-urgent appointment if you notice gradually increasing breathlessness, fatigue, palpitations or ankle swelling, or if a doctor has found a heart murmur. If you already know you have mitral valve disease, contact your cardiology team promptly if symptoms worsen, exercise tolerance drops, or you develop a persistent irregular heartbeat. Do not wait for symptoms to become severe — correct timing protects the heart.

19. Disease Stages, Grades and Severity

Cardiologists grade mitral valve disease by severity and stage:

Regurgitation severity — graded mild, moderate or severe based on echocardiographic measures such as the regurgitant volume, effective regurgitant orifice area and the width of the leaking jet.
Stenosis severity — graded by the mitral valve area (roughly: mild >1.5 cm², moderate 1.0–1.5 cm², severe <1.0 cm²) and the pressure gradient across the valve.
Staging (ACC/AHA framework): Stage A (at risk), Stage B (progressive but symptom-free), Stage C (severe but symptom-free), and Stage D (severe with symptoms). This staging helps decide the timing of intervention.

20. Disease Progression

Mitral valve disease usually advances slowly over years. In degenerative regurgitation a mild leak may stay stable or progress as leaflet tissue weakens, occasionally jumping abruptly if a cord ruptures. Rheumatic stenosis narrows steadily over decades, and functional MR tracks with the underlying heart-muscle disease. Key milestones marking progression include the onset of atrial fibrillation, the appearance of symptoms, enlargement of the left atrium or ventricle, and rising pulmonary artery pressure. Regular echocardiograms track these changes so intervention can be timed before permanent damage occurs.

21. Possible Complications

Atrial fibrillation — the most common complication, causing palpitations and clot risk
Stroke and systemic embolism — from clots forming in the enlarged, fibrillating atrium
Heart failure — the left ventricle weakens or the lungs become congested
Pulmonary hypertension — raised lung-artery pressure straining the right heart
Right heart failure — leg swelling, ascites and liver congestion
Infective endocarditis — infection of the abnormal valve
Sudden worsening from ruptured chordae in degenerative disease

Mitral valve disease often coexists with other cardiovascular problems:

Other valve diseases — aortic valve disease, tricuspid valve disease, or combined multi-valvular disease
Coronary artery disease — a frequent companion, especially with functional MR
Heart failure and cardiomyopathy
Atrial fibrillation and other rhythm disorders
Pulmonary hypertension and lung disease
Infective endocarditis
Connective-tissue disorders such as Marfan syndrome

23. Screening and Early Detection

There is no population-wide screening programme, but mitral valve disease is often detected early when a doctor hears a heart murmur during a routine examination and orders an echocardiogram. People with a family history of prolapse or connective-tissue disorders, past rheumatic fever, or a previous heart attack may be screened proactively. In regions where rheumatic heart disease is common, echocardiographic screening of schoolchildren can catch early disease. Anyone with unexplained breathlessness, palpitations or a known murmur should have an echocardiogram.

24. How the Disease Is Diagnosed

Diagnosis usually begins when a clinician hears an abnormal heart sound: a leaking valve typically produces a systolic murmur at the apex, while a narrowed valve produces a low-pitched diastolic rumble. These findings prompt further testing.

The cornerstone of diagnosis is the echocardiogram — an ultrasound scan that shows the valve moving in real time, measures how severely it leaks or narrows, and assesses the size and pumping strength of the chambers. A standard transthoracic echo is done first; a more detailed transoesophageal echo (TOE/TEE) gives close-up images and is especially useful for planning repair. An ECG looks for atrial fibrillation and chamber enlargement, and a chest X-ray shows heart size and lung congestion.

For selected patients, doctors add a cardiac MRI, a CT scan before catheter procedures, an exercise (stress) echo to unmask symptoms, and coronary angiography before surgery. Together these tests confirm the type, severity and cause of the valve problem and guide treatment.

25. Physical Examination and Medical History

The doctor asks about breathlessness, fatigue, palpitations, chest discomfort, fainting, and any history of rheumatic fever, heart attack, dental infections or family valve disease. On examination they listen for the characteristic murmurs — a blowing systolic murmur at the apex for regurgitation, or a rumbling diastolic murmur with an “opening snap” for stenosis. They also check the pulse for irregularity, look for raised neck veins, listen to the lungs for crackles, and examine the ankles for fluid retention. These clues guide which tests are ordered.

26. Diagnostic Tests and Imaging

Transthoracic echocardiogram (TTE) — first-line; confirms and grades the disease
Transoesophageal / 3D echocardiography — detailed leaflet images for surgical or catheter planning
Electrocardiogram (ECG) — detects atrial fibrillation and chamber strain
Chest X-ray — heart size and lung congestion
Cardiac MRI — precise measurement of leak severity and ventricular function
CT scan — calcium scoring and anatomy before transcatheter procedures
Exercise / stress echo — assesses symptoms and pressures under exertion
Coronary angiography — checks the coronary arteries before surgery

27. Blood Tests, Biomarkers and Genetic Testing

No blood test diagnoses mitral valve disease directly, but blood work supports assessment. BNP or NT-proBNP rise when the heart is under strain and help judge and track the valve’s impact. Full blood count may reveal anaemia that worsens symptoms; kidney/liver function and electrolytes guide medication and surgical fitness; thyroid tests help evaluate atrial fibrillation. If endocarditis is suspected, blood cultures are essential. Genetic testing is reserved for suspected inherited connective-tissue disorders or familial prolapse.

28. Understanding Test Results

Your echocardiogram report describes the severity of the leak or narrowing, the mitral valve area or regurgitant volume, and the ejection fraction (how well the left ventricle pumps, normally about 55–70%). It also notes the size of the left atrium and ventricle and the estimated pulmonary artery pressure. Rising chamber sizes, a falling ejection fraction or increasing lung pressure suggest the heart is beginning to suffer and intervention may be needed soon. Ask your cardiologist to explain your specific numbers.

29. Differential Diagnosis

Because breathlessness, fatigue and murmurs have many causes, doctors rule out other conditions before settling on mitral valve disease:

Other valve problems — aortic stenosis/regurgitation, tricuspid disease
Heart failure from coronary disease or cardiomyopathy without a valve leak
Lung conditions — COPD, asthma, pulmonary embolism
Anaemia or thyroid disease causing breathlessness and palpitations
Innocent (functional) murmurs and congenital septal defects

The echocardiogram usually settles the diagnosis.

30. Specialist and Multidisciplinary Evaluation

Significant mitral valve disease is best managed by a Heart Valve Team — a multidisciplinary group that reviews complex cases together. It typically includes a cardiologist, a cardiac surgeon experienced in valve repair, an interventional (structural) cardiologist, an imaging specialist, and often an anaesthetist and heart-failure specialist. Meeting as a team lets them weigh repair versus replacement versus a transcatheter option, considering your anatomy, overall health and wishes. You can find experienced cardiologists and specialist hospitals through this site.

31. Treatment Goals

The main aims of treatment are to:

Relieve symptoms such as breathlessness and fatigue
Protect the heart from progressive enlargement and weakening
Prevent complications — heart failure, stroke and pulmonary hypertension
Restore normal blood flow and, where possible, preserve the patient’s own valve (repair over replacement)
Improve quality of life and long-term survival

Getting the timing right — intervening before irreversible damage but not unnecessarily early — is central to good outcomes.

32. When Is Treatment Required?

Not everyone needs a procedure. Treatment beyond monitoring is usually considered when:

The disease is severe and causing symptoms
The valve is severe and, even without symptoms, the heart shows signs of suffering — enlarging ventricle, falling ejection fraction, new atrial fibrillation, or rising pulmonary pressure
For mitral stenosis, when the valve area is significantly reduced and symptoms or pulmonary hypertension appear

Mild and moderate disease is generally watched. Because the ideal window can be subtle, these decisions are made with a specialist valve team.

33. Active Monitoring and Watchful Waiting

For mild and moderate disease, and for some people with severe disease who have no symptoms and a well-functioning heart, careful observation is the right approach. This means regular echocardiograms — often every 6–12 months for severe disease and every 1–3 years for milder disease — to watch valve severity, chamber size, pumping strength and lung pressure, with patients taught which symptoms to report. Watchful waiting avoids unnecessary surgery while ensuring intervention happens at the right moment.

34. Medications

Medicines do not fix the mechanical problem, but they control symptoms and complications:

Diuretics (“water tablets”) — relieve fluid build-up and breathlessness
Beta-blockers or calcium-channel blockers — slow the heart rate, helpful in mitral stenosis and atrial fibrillation
Anticoagulants (blood thinners) — warfarin or DOACs to prevent stroke in atrial fibrillation; warfarin is required for mechanical valves and rheumatic stenosis with AF
ACE inhibitors, ARBs and heart-failure drugs — for functional MR and reduced pumping function
Antiarrhythmic drugs — to control atrial fibrillation
Antibiotics — to treat or, in selected cases, prevent valve infection

35. Minimally Invasive Treatments

Many mitral operations can now be done through small incisions rather than a full breastbone opening. Minimally invasive mitral surgery uses a small cut between the ribs on the right chest, often with video or robotic assistance, to repair or replace the valve. Benefits can include less pain, smaller scars, lower blood loss, shorter stays and faster recovery. Robotic and endoscopic approaches are offered at high-volume centres. You can explore minimally invasive cardiac surgery options through this site.

36. Catheter-Based and Endovascular Treatments

For patients too frail or high-risk for surgery, catheter-based (percutaneous) treatments avoid opening the chest:

Transcatheter edge-to-edge repair (TEER), e.g. MitraClip — a clip delivered through a leg vein grips the leaflets together to reduce the leak; a leading option for severe regurgitation in poor surgical candidates.
Percutaneous (balloon) mitral valvuloplasty — for suitable rheumatic stenosis, a balloon widens the narrowed opening, often delaying or avoiding surgery.
Transcatheter mitral valve replacement (TMVR) — an emerging option, mainly in trials or for failed prior valves.

37. Surgical Treatment Options

Surgery remains the gold standard for many patients with severe mitral valve disease, with two broad approaches: repair and replacement.

Mitral valve repair is preferred whenever possible, especially for degenerative regurgitation. The surgeon reshapes the patient’s own valve — trimming or re-suspending prolapsing tissue, replacing broken cords, and reinforcing the ring with an annuloplasty ring. Repair preserves the natural valve, generally avoids lifelong blood thinners, carries a lower infection risk, and offers excellent durability and survival in experienced hands.

Mitral valve replacement is used when the valve is too damaged to repair, common in severe rheumatic or heavily calcified valves. It is replaced with either a mechanical valve (very durable but requiring lifelong warfarin) or a biological (tissue) valve (no long-term blood thinner but may wear out over 10–20 years). The choice depends on age, bleeding risk and preference.

Surgery may be done through a full sternotomy or minimally invasive/robotic approaches, and is often combined with bypass, other valve work, or an atrial fibrillation ablation (Maze). Explore mitral valve procedures and top surgery centres through this site.

38. Advanced and Emerging Treatments

Mitral valve care is advancing rapidly. Transcatheter mitral valve replacement (TMVR) devices are in trials for patients unsuitable for surgery or clip repair, and refined edge-to-edge repair systems are broadening the anatomy that can be treated. Transcatheter annuloplasty and chordal-replacement devices aim to fix specific parts of the valve without surgery, while robotic surgery, 3D imaging and AI-assisted planning improve precision. Many of these are available through clinical trials or at leading specialist centres.

39. Treatment Options Compared

Medication only — controls symptoms, does not fix the valve; used for mild disease or when procedures are not suitable
Balloon valvuloplasty — good for suitable rheumatic stenosis; less invasive, repeatable, but not for heavily calcified or leaking valves
MitraClip / TEER — avoids surgery, ideal for high-risk regurgitation patients; may reduce rather than fully abolish the leak
Surgical repair — most durable for degenerative MR, preserves the natural valve; requires open or minimally invasive surgery
Valve replacement — definitive when repair is impossible; mechanical valves need lifelong warfarin, tissue valves may need later re-replacement

The best choice depends on valve type, anatomy, age and overall health.

40. How Doctors Choose the Right Treatment

The Heart Valve Team weighs several factors:

Type and cause of the disease (regurgitation vs stenosis; degenerative vs functional vs rheumatic)
Severity and symptoms, and how the heart chambers and lungs are responding
Whether the valve can be repaired rather than replaced
Surgical risk — age, frailty, other illnesses, previous heart surgery
Coexisting conditions — coronary disease, other valves, atrial fibrillation
Patient preferences and lifestyle (for example, avoiding lifelong blood thinners)

Shared decision-making ensures the plan fits both the anatomy and the person.

41. Benefits and Risks of Treatment

Benefits: relief of breathlessness and fatigue, protection of the heart from further damage, lower risk of heart failure and stroke, and improved quality of life and survival — especially with timely valve repair.

Risks: as with any heart procedure, possible bleeding, infection, stroke, rhythm disturbances needing a pacemaker, and rarely reoperation. Mechanical valves carry a lifelong bleeding/clotting risk from anticoagulation; tissue valves may degenerate over time; catheter procedures may not fully correct the leak. At experienced, high-volume centres the risks are low and the benefits generally outweigh them for suitable patients.

42. What Happens If the Disease Is Left Untreated?

Untreated severe mitral valve disease tends to worsen. Persistent volume or pressure overload gradually enlarges and weakens the left ventricle, sometimes irreversibly, and raises lung pressure. The stretched left atrium triggers atrial fibrillation and its risk of stroke. Over time symptoms progress to disabling breathlessness, fluid retention and heart failure, and the right heart can fail too. Severe symptomatic disease carries a poor prognosis untreated, which is why intervening at the right time — before the heart is severely damaged — matters.

43. Treatment Success and Expected Outcomes

Outcomes are generally very good when treatment is well-timed and performed by experienced teams. Mitral valve repair for degenerative disease has excellent durability, with most patients enjoying lasting symptom relief and a near-normal life expectancy. Valve replacement also relieves symptoms effectively, tissue valves lasting many years and mechanical valves decades. MitraClip/TEER improves symptoms in selected high-risk patients, and balloon valvuloplasty for rheumatic stenosis can give years of benefit. Results depend on timing, cause and the centre’s expertise, so figures vary between patients.

44. Prognosis and Long-Term Outlook

The long-term outlook is generally favourable, particularly when the condition is treated before the heart is permanently damaged. People with mild or moderate disease often live normal lives for years with simple monitoring. Those who undergo timely valve repair typically have an outlook approaching that of people without valve disease, and repair is associated with better long-term survival than replacement in suitable degenerative cases.

Prognosis is less favourable when treatment is delayed until the ventricle is severely weakened, when functional MR reflects advanced heart-muscle disease, or when significant pulmonary hypertension or persistent atrial fibrillation have developed. Even then, modern treatments — including catheter options for high-risk patients — can substantially improve symptoms and quality of life. With the right care at the right time, most people with mitral valve disease do well.

45. Recovery and Rehabilitation

Recovery depends on the procedure. After minimally invasive or catheter-based treatment, many patients go home within days and resume normal activities in two to four weeks. After open surgery, the stay is usually 5–7 days, the breastbone heals over 6–8 weeks and full activity returns within two to three months. Cardiac rehabilitation — supervised graded exercise, education and lifestyle support — speeds recovery, alongside wound care, gradual walking and taking prescribed medicines.

46. Follow-Up Tests and Long-Term Monitoring

After treatment, lifelong follow-up protects the result. Expect periodic echocardiograms to check valve function, an ECG to monitor rhythm, and blood tests. Patients on warfarin need regular INR monitoring, and those with a mechanical valve or ongoing atrial fibrillation continue anticoagulation. Watchful-waiting patients also need scheduled echocardiograms to catch progression early. Keep all follow-up appointments even if you feel completely well.

47. Managing Recurrence or Disease Progression

Valve disease can recur or progress. A repaired valve occasionally leaks again, and a tissue valve gradually wears out and may need re-doing — increasingly via a valve-in-valve catheter procedure rather than repeat open surgery. In watchful-waiting patients, progression to severe disease triggers intervention. Ongoing management focuses on controlling atrial fibrillation, treating heart failure, maintaining anticoagulation where needed, and regular imaging to catch deterioration early.

48. Living with the Disease

Most people with mitral valve disease live active, full lives. Living well means staying on top of medications, attending follow-up appointments, and reporting new symptoms such as increasing breathlessness or palpitations. Good dental hygiene reduces valve-infection risk. Managing blood pressure, staying active within advised limits, not smoking and keeping a healthy weight all support the heart. Patients on blood thinners should carry a medical alert card and avoid injury. With sensible self-care and regular review, the condition need not dominate daily life.

49. Diet and Nutrition Guidelines

Follow a heart-healthy diet rich in vegetables, fruit, whole grains, legumes, fish and healthy fats (Mediterranean-style)
Limit salt to reduce fluid retention and ease breathlessness, especially if you have heart failure
Watch fluid intake if advised by your doctor
Keep alcohol within recommended limits — excess can trigger atrial fibrillation
If taking warfarin, keep your intake of vitamin-K-rich foods (leafy greens) steady rather than fluctuating, and discuss any big diet changes with your team
Maintain a healthy weight to reduce the heart’s workload

50. Exercise and Physical-Activity Guidelines

Regular, moderate physical activity is beneficial for most people with mitral valve disease and should be tailored to severity. Those with mild disease can usually exercise normally, while people with severe disease or symptoms may need to limit strenuous or competitive activity until treated. Gentle aerobic activity such as walking, cycling and swimming is generally encouraged; heavy weightlifting and intense competitive sport should be discussed with your cardiologist. After a procedure, activity is increased gradually, ideally through cardiac rehabilitation. Always agree an exercise plan with your specialist, especially if you have symptoms, atrial fibrillation or pulmonary hypertension.

51. Medications, Activities and Habits to Avoid

Do not stop prescribed medicines — especially blood thinners — without medical advice
Avoid smoking and recreational drugs (IV drug use greatly raises endocarditis risk)
Limit excess alcohol, which can trigger atrial fibrillation
Be cautious with NSAIDs and some over-the-counter/herbal remedies, which can interact with warfarin or cause fluid retention — check with your pharmacist
Avoid strenuous competitive sport if you have severe or symptomatic disease until cleared
Do not ignore dental infections; keep up good oral hygiene and inform dentists of your valve condition

52. Preventing the Disease or Reducing Its Risks

Some causes are preventable. Prompt antibiotic treatment of strep throat in children prevents rheumatic fever, the leading cause of mitral stenosis worldwide. Good dental and skin hygiene reduces endocarditis risk. Controlling blood pressure, not smoking and managing coronary risk factors help prevent the heart attacks and heart failure behind functional MR. Degenerative disease cannot always be prevented, but early detection and timely treatment allow the best outcomes.

53. Pregnancy and the Disease

Pregnancy places extra demands on the heart, and mitral valve disease — particularly mitral stenosis — can worsen or first appear during pregnancy. Women planning pregnancy should have a pre-pregnancy cardiology review to assess risk and, if needed, treat the valve beforehand (balloon valvuloplasty can sometimes be done in pregnancy for severe stenosis). Anticoagulation needs careful planning, as warfarin can affect the baby. With specialist obstetric-cardiology care, many women have safe pregnancies, but individual advice is essential.

54. Disease in Children and Young Adults

In children and young adults, mitral valve disease is most often due to congenital abnormalities or rheumatic fever, the latter still common in many low- and middle-income regions. Mitral valve prolapse and inherited disorders such as Marfan syndrome may also present young. Young patients are followed closely, and valve repair is especially favoured to preserve their own tissue and avoid lifelong anticoagulation. Preventing and treating rheumatic fever is key in this age group.

55. Disease in Older Adults

In older adults, degenerative regurgitation, heavily calcified valves and functional MR from coronary disease and heart failure are the common forms. Elderly patients often have other conditions that raise surgical risk, which is why catheter-based options such as MitraClip and less invasive approaches are so valuable here. Decisions weigh likely benefit against frailty and are best made by a valve team with the patient and family. Age alone is not a barrier to successful treatment.

56. Emotional Health and Patient Support

A diagnosis of valve disease, or facing surgery, can cause anxiety, low mood and worry — these feelings are normal. Talking with your care team, connecting with patient support groups and involving family all help, and cardiac rehabilitation often includes psychological support. If anxiety or depression persists, ask about counselling; good emotional health supports recovery. You are not alone, and effective treatment usually restores both confidence and quality of life.

57. Preparing for Your Specialist Appointment

Write down your symptoms, when they started and what makes them better or worse
List all your medications, doses and allergies
Note your medical history, including any rheumatic fever, heart attack or family valve disease
Bring copies of previous echocardiograms, ECGs and test results if available
Prepare your questions in advance (see next section)
Bring a family member or friend to help remember information
Note any lifestyle factors — smoking, alcohol, exercise — your doctor may ask about

58. Questions to Ask Your Doctor

What type of mitral valve disease do I have, and how severe is it?
Is my valve leaking, narrowed, or both?
What is causing it, and is it likely to get worse?
Do I need treatment now, or can we monitor it safely?
Can my valve be repaired, or would it need replacing?
Am I a candidate for a minimally invasive or MitraClip/catheter procedure?
What are the risks and benefits of each option for me?
Will I need blood thinners, and for how long?
How will treatment affect my daily life, work and activity?
How often will I need follow-up scans and tests?

59. Cost of Diagnosis and Treatment

Costs vary widely by country, hospital and the exact procedure. The figures below are approximate US-dollar ranges for guidance only.

Country / Region	Mitral Valve Repair/Replacement (approx.)	MitraClip / TEER (approx.)
United States	$80,000 – $200,000+	$35,000 – $80,000+
United Kingdom (private)	£25,000 – £60,000	£25,000 – £45,000
India	$6,000 – $12,000	$18,000 – $30,000
Turkey	$10,000 – $20,000	$20,000 – $35,000
Thailand	$12,000 – $25,000	$25,000 – $40,000
Singapore	$25,000 – $50,000	$35,000 – $60,000

Medical-tourism destinations such as India, Turkey and Thailand often cost roughly 50–90% less than the US or UK for comparable quality. Always confirm what the quote includes (surgeon, hospital, implant, ICU, follow-up).

60. Factors Affecting Treatment Cost

Type of procedure — repair vs replacement vs catheter (MitraClip/valvuloplasty)
Type of valve or device used (mechanical, tissue, clip)
Surgical approach — open vs minimally invasive or robotic
Hospital accreditation, reputation and location
Surgeon’s experience and volume
Length of hospital and ICU stay
Additional procedures — bypass, other valves, AF ablation
Pre-operative tests, follow-up and rehabilitation
Complications, if any, and insurance or package arrangements

61. Choosing the Right Specialist

Look for a cardiologist and cardiac surgeon with specific expertise in mitral valve disease and a strong track record in valve repair, which requires more skill than replacement. Ask how many mitral procedures they do each year and their repair, complication and success rates. Structural procedures such as MitraClip should be done by an experienced interventional cardiologist. Board certification, subspecialty training and access to a full Heart Valve Team are important markers of quality. Browse experienced doctors through this site.

62. Choosing the Right Hospital or Treatment Centre

Choose a high-volume valve centre — outcomes are linked to experience
Look for international accreditation such as JCI (Joint Commission International)
Confirm a full Heart Valve Team and modern imaging
Ask about repair rates and complication/reoperation statistics
Check facilities for minimally invasive, robotic and catheter procedures
For international patients, review language, travel and aftercare arrangements

Explore accredited hospitals and top destinations for cardiac care.

63. Getting a Second Medical Opinion

A second opinion is worthwhile before any major valve procedure, particularly to confirm whether your valve can be repaired rather than replaced and whether a less invasive option is suitable. A fresh review of your echocardiograms by an experienced valve team can change the recommendation and improve your outcome. Seeking another opinion is routine and sensible — good doctors welcome it. You can request a second opinion through this site.

64. Treatment Abroad and Medical-Travel Considerations

Many patients travel abroad for mitral valve treatment to access high-quality care at lower cost or with shorter waits. Leading destinations include India, Turkey, Thailand and Singapore, home to JCI-accredited hospitals and internationally trained surgeons. When planning, consider:

Hospital accreditation and the surgeon’s experience and repair rates
Total cost transparency, including implants, ICU and follow-up
Travel timing — you may need to stay several weeks; flying too soon after surgery carries risks
Continuity of care — how follow-up and complications will be managed back home
Anticoagulation management if you receive a mechanical valve

Explore destinations and hospitals to plan safe medical travel.

65. Frequently Asked Questions

Is mitral valve disease serious? It ranges from mild and harmless to severe and life-limiting. Mild disease is simply monitored; severe disease is very treatable but should not be ignored.

Can it be cured? Medications control symptoms but do not fix the valve. Repair or replacement corrects the mechanical problem, and repair in particular offers excellent, durable results.

Is valve repair better than replacement? For degenerative regurgitation, repair is generally preferred — it keeps your own valve, usually avoids lifelong blood thinners and offers better long-term survival. When the valve is too damaged, replacement is used.

What is a MitraClip? A small clip delivered by catheter that clips the leaflets together to reduce a leak without open surgery — mainly for high surgical-risk patients.

Will I need blood thinners? A mechanical valve requires lifelong warfarin. Repairs and tissue valves usually do not, unless you also have atrial fibrillation.

Can I exercise? Most people can and should stay active, at an intensity tailored to your severity and agreed with your cardiologist.

Does it shorten life? Well-timed treatment restores a near-normal outlook for many patients; delaying treatment of severe disease worsens it.

66. Patient Stories and Treatment Experiences

The following are representative, anonymised examples for illustration only.

Anita, India — Diagnosed with rheumatic mitral stenosis in her 30s after breathlessness in pregnancy, Anita had balloon valvuloplasty. Her symptoms eased quickly and she has stayed well on follow-up.

David, United Kingdom — A routine check-up in his 60s revealed a murmur and severe degenerative regurgitation. He had minimally invasive valve repair, went home within days, and returned to golf within two months.

Miguel, Spain — With heart failure and functional MR too high-risk for surgery, Miguel received a MitraClip. His breathlessness improved markedly and he could again enjoy time with his grandchildren.

67. Latest Research and Clinical Trials

Mitral valve treatment is a fast-moving field. Research is expanding transcatheter edge-to-edge repair (TEER) to more patients, including those with functional MR. Transcatheter mitral valve replacement (TMVR) devices are in trials for people unsuitable for surgery or clip repair, and valve-in-valve techniques are improving treatment of worn-out tissue valves. Other advances include newer annuloplasty and chordal-repair devices, robotic surgery and AI-assisted imaging. Patients interested in trials should ask their valve team; participation is voluntary and access varies by centre and country.

70. Medical Glossary

Mitral valve — the two-leaflet valve between the left atrium and left ventricle
Regurgitation (MR) — backward leaking of blood through the valve
Stenosis (MS) — narrowing of the valve opening
Prolapse (MVP) — bulging of a leaflet back into the atrium
Annulus — the ring of tissue supporting the valve leaflets
Annuloplasty — surgical reinforcement of the valve ring, often with a ring or band
Chordae tendineae — thin cords anchoring the leaflets to the ventricle
Ejection fraction — percentage of blood pumped out of the ventricle each beat
Atrial fibrillation — an irregular, often rapid heart rhythm
Echocardiogram — ultrasound scan of the heart
TEER / MitraClip — transcatheter edge-to-edge leaflet repair
Valvuloplasty — balloon widening of a narrowed valve
Endocarditis — infection of the heart valve or lining
Pulmonary hypertension — raised pressure in the lung arteries

71. Medical Review, Editorial Policy and Last Updated Date

Last updated: 11 July 2026.

This article is written for patient education and reviewed against current cardiology guidance from bodies such as the ACC/AHA, the ESC/EACTS and the NHS. Our editorial policy emphasises accuracy, clarity and balance; content is reviewed by qualified medical professionals and updated as practice evolves.

Disclaimer: This information is educational and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified cardiologist or your own doctor about your specific condition and before making any treatment decisions.

72. Clinical Guidelines and Medical References

This content reflects general, widely accepted knowledge and current guidance from reputable organisations, including:

American College of Cardiology (ACC) and American Heart Association (AHA) valvular heart disease guidelines
European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines on valvular heart disease
Society of Thoracic Surgeons (STS) resources
National Health Service (NHS) patient information
World Health Organization (WHO) materials on rheumatic heart disease
Standard cardiology and cardiac-surgery textbooks

Please consult a healthcare professional and the latest guideline versions for clinical decisions.

73. Book an Appointment or Request a Second Opinion

If you or a loved one has mitral valve disease, expert help is available. Our partner network of leading cardiologists, cardiac surgeons and accredited hospitals can review your case, confirm the diagnosis and recommend the best treatment — including valve repair, replacement and catheter-based options such as MitraClip.

Book an appointment: Get started here
Request a second opinion or ask a question: Contact us
Explore top hospitals, experienced doctors and leading destinations for cardiac care.

Taking action early gives you the best chance of a healthy heart and a full life.

Mitral Valve Disease